Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with ...

Bispecific antibodies, which bind to two targets, are sweeping into the clinic and are prompting even more elaborate versions.

Antibodies are an important defense against SARS-CoV-2, but the virus continues to evolve ways to evade them. Now, ...

Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a cell line development partnership with Kaigene, a biotechnology company ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

(ADCs) and renewing interest in targeted radioimmunoconjugates highlighted by commercial momentum and patent consolidation from Roche/Genentech, Daiichi Sankyo, Gilead Sciences, AstraZeneca, Pfizer, ...

Certain antiphospholipid antibody profiles are associated with increased odds of adverse pregnancy outcomes in women with ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Several types of antibody-mediated diseases are known. Some are thought to be adverse effects of vaccination, which is logical since vaccines, by definition, cause their effects via stimulation of the ...

Monoclonal antibodies (mAbs) are a class of biologic drugs used to treat rheumatoid arthritis if other treatments aren’t effective. mAbs target specific parts of the immune system to reduce ...